Cerity Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.85M Buy
46,552
+6,184
+15% +$777K 0.01% 740
2025
Q1
$5.52M Buy
40,368
+18,277
+83% +$2.5M 0.01% 697
2024
Q4
$3.52M Buy
22,091
+14,306
+184% +$2.28M 0.01% 850
2024
Q3
$1.51M Buy
7,785
+2,030
+35% +$393K ﹤0.01% 1214
2024
Q2
$1.33M Sell
5,755
-631
-10% -$146K ﹤0.01% 1098
2024
Q1
$1.38M Buy
6,386
+3,708
+138% +$800K ﹤0.01% 1134
2023
Q4
$693K Buy
2,678
+360
+16% +$93.2K ﹤0.01% 1122
2023
Q3
$596K Sell
2,318
-768
-25% -$197K ﹤0.01% 913
2023
Q2
$879K Buy
3,086
+1,344
+77% +$383K ﹤0.01% 965
2023
Q1
$1.32M Sell
1,742
-227
-12% -$171K ﹤0.01% 864
2022
Q4
$545K Buy
1,969
+386
+24% +$107K ﹤0.01% 903
2022
Q3
$422K Buy
1,583
+82
+5% +$21.9K 0.01% 776
2022
Q2
$305K Buy
+1,501
New +$305K ﹤0.01% 901
2022
Q1
Sell
-860
Closed -$208K 950
2021
Q4
$208K Buy
+860
New +$208K ﹤0.01% 919
2021
Q1
Sell
-1,129
Closed -$277K 700
2020
Q4
$277K Sell
1,129
-1,574
-58% -$386K 0.01% 540
2020
Q3
$767K Sell
2,703
-70
-3% -$19.9K 0.03% 271
2020
Q2
$742K Buy
2,773
+374
+16% +$100K 0.04% 235
2020
Q1
$759K Sell
2,399
-167
-7% -$52.8K 0.05% 243
2019
Q4
$761K Buy
+2,566
New +$761K 0.04% 277
2019
Q2
Sell
-1,502
Closed -$355K 493
2019
Q1
$355K Sell
1,502
-648
-30% -$153K 0.02% 384
2018
Q4
$647K Buy
2,150
+272
+14% +$81.9K 0.04% 285
2018
Q3
$664K Sell
1,878
-65
-3% -$23K 0.05% 294
2018
Q2
$564K Buy
1,943
+769
+66% +$223K 0.04% 312
2018
Q1
$321K Sell
1,174
-150
-11% -$41K 0.02% 418
2017
Q4
$422K Sell
1,324
-103
-7% -$32.8K 0.03% 365
2017
Q3
$447K Sell
1,427
-549
-28% -$172K 0.03% 341
2017
Q2
$536K Buy
1,976
+208
+12% +$56.4K 0.04% 222
2017
Q1
$483K Buy
+1,768
New +$483K 0.04% 264